Fig. 1 · Structure

Documents & Downloads

Lexosiran

ANGPTL3 synthesis reducer

Lexosiran is a small interfering RNA (siRNA) that reduces the synthesis of angiopoietin-related protein 3 (ANGPTL3). By inhibiting ANGPTL3, Lexosiran plays a significant role in lipid metabolism and may serve as a valuable tool in the study of antihyperlipidemic strategies. Its application extends to elucidating the biological pathways involved in lipid regulation and exploring therapeutic avenues for dyslipidemia.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
CAS Number 3078403-66-1
Applications ANGPTL3 synthesis reducer
Molecular Weight 15667.90

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...